Reven Holdings Inc

Golden, CO · Founded 2018 · CIK 0001751949 · Biotech · Private

Pharmaceutical compounds and therapeutics developed through scientific research

reven.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$200K
1 Form D · Sep 2018
97 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$200,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2629Zepteon, Inc—$210K
2630VERRA THERAPEUTICS LLC—$205K
2631ELDEC PHARMACEUTICALS INC.—$200K
2632Reven Holdings Inc—$200K
2633NonExomics, Inc.—$200K
2634FruitVaccine Incorporation——
2635Amalgent Therapeutics, LLC—$200K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Brian DenommeDirector · Executive Officer
  • Michael HandleyDirector · Executive Officer
  • Peter LangeDirector · Executive Officer
  • Michael VolkDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.